Search
Close this search box.

PI – DNP Development & Adoption

Standard software allowing true plug and play of unit op components, reducing automation changes from months to days.
Categories
Proteins/ Antibodies
Project status
96% Completed

Industry Need

Automation changes take weeks to months, often on critical path for tech transfer.

Solution

Standard and software allowing true plug and play of unit op components.

Outputs/Deliverables

  • Interchangeability Demonstrations – SMART O2 sensors from different vendors used to connect to same HMI using the DNP / MTP automation platform while in-process (Complete December 7, 2021).
  • Reconfigurability Demonstrations – added new processing capability (glucose control) during pre-process equipment setup without re-programming the HMI and process orchestration layer (Complete July 11, 2023) .
  • Randolph, P., Rode, C., Polilli, B., Fejoz, L., Reinbigler, R., Phillips, M., Hart, R., Erickson, J., Kaneshiro, S. Bringing Flexibility to Integrated Continuous Biomanufacturing. Poster presentation at ICB, October 12, 2022.

Impacts

Reduce reconfiguration downtime from months to days (assume 4 wks savings).

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access more, including: 

  • Updates
  • Value Proposition
  • Related Publications
  • Deliverables

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

NIIMBL

NIIMBL

Participating Organizations

3M Company

3M Company

Amgen Inc.

Amgen Inc.

Bristol-Myers Squibb

Bristol-Myers Squibb

CSL Behring, LLC

CSL Behring, LLC

Cytiva

Cytiva

Eli Lilly and Company

Eli Lilly and Company

GlaxoSmithKline, LLC

GlaxoSmithKline, LLC

Janssen Research & Development, LLC

Janssen Research & Development, LLC

Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC

MilliporeSigma/EMD Serono

MilliporeSigma/EMD Serono

Pfizer, Inc.

Pfizer, Inc.

Sanofi

Sanofi

Sartorius Stedim

Sartorius Stedim